Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01076296 · ClinicalTrials.gov registry record
A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System
A clinical trial of Pulmonary Hypertension and Heart Valve Diseases, sponsored by GE Healthcare.
- Completed
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT01076296: Completed study of Pulmonary Hypertension and Heart Valve Diseases, sponsored by GE Healthcare.
NCT01076296 is a study of Pulmonary Hypertension and Heart Valve Diseases that has completed, run by GE Healthcare. The registered enrollment target is 1,000 participants, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01076296, a study of Pulmonary Hypertension and Heart Valve Diseases, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to collect data and learn more about the Vscan Ultrasound Imaging System. It is an "observational" study with no additional procedures or intervention prescribed other than using the Vscan along with a routine medical physical exam.
Primary Outcome
A comparison of the percentages of correct diagnosis by VSCAN and clinical exam using a McNemar test for matched pairs with ECHO used as the gold standard.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-07 |
What the finished NCT01076296 record still lists
NCT01076296 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher).
The record links to 4 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT01076296 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT01076296 about?
NCT01076296 is a clinical study titled "A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System". This study is to collect data and learn more about the Vscan Ultrasound Imaging System. It is an "observational" study with no additional procedures or intervention prescribed other than using the Vscan along with a routine medical physical exam.
What is the current status of trial NCT01076296?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2010-02. Estimated completion is 2012-07.
What conditions does trial NCT01076296 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Heart Valve Diseases, Left Ventricular Dysfunction, Right Ventricular Dysfunction.
Who is sponsoring clinical trial NCT01076296?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01076296 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01076296's enrollment target sits among peer trials
1,000 8th of 72 higher than 63 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia